Induction of interleukin-2 receptor α (IL-2Rα) expression by interleukin-2:: important role of the interleukin-2 receptor β chain region between the two Stat5 docking sites

被引:0
作者
Imbert, V [2 ]
Rezzonico, R
Reichenbach, P
Nabholz, M
机构
[1] ISREC, Lymphocyte Biol Unit, CH-1066 Epalinges, Switzerland
[2] Fac Med Pasteur, INSERM, U364, F-06107 Nice 02, France
关键词
Stat5; IL-2; receptor; T lymphocytes; CD25;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interleukin-2 receptor alpha (IL-2Ralpha) forms, together with IL-2Rbeta and gammac chains, a high affinity IL-2 receptor that is important for IL-2 responsiveness and normal T cell function. Expression of the IL-2Ralpha gene by T cells is regulated mainly at the transcription level which is transiently activated by antigen and upregulated and then prolonged by stimulation with IL-2. The effect of IL-2 on the IL-2Ralpha gene depends on the activation of the transcription factor Stat5, which acts on an IL-2- responsive enhancer that consists of two Stat5 and an Elf1 binding site. To identify the functional domains of the IL-2 receptor required for the stimulation of IL-2Ralpha gene expression, we introduced, into the CTL44 T cell line, receptor chimeras between the extracellular domain of the IL-9 receptor and the cytoplasmic region of IL-2Rbeta. Analyzing the effect of mutations in the intracellular IL-2Rbeta segment, we found that a minimal receptor containing the Jak boxes and one intact Stat5 docking site (i.e. tyrosine 392 or 510) can, as expected, mediate Stat5 activation, but is unable to stimulate IL-2Ralpha expression. However, when this minimal receptor includes the region between the two tyrosines, its capacity to mediate IL-2Ralpha cell surface expression is restored. These data suggest that the segment between the two Stat5 docking sites of the IL-2Rbeta chain mediates signaling events that, together with Stat5 activation, are essential for the stimulation of IL-2Ralpha gene transcription.
引用
收藏
页码:331 / 339
页数:9
相关论文
共 40 条
[1]   Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene [J].
Ascherman, DP ;
Migone, TS ;
Friedmann, MC ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) :8704-8709
[2]   Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway [J].
Beadling, C ;
Ng, J ;
Babbage, JW ;
Cantrell, DA .
EMBO JOURNAL, 1996, 15 (08) :1902-1913
[3]   ACTIVATION OF JAK KINASES AND STAT PROTEINS BY INTERLEUKIN-2 AND INTERFERON-ALPHA, BUT NOT THE T-CELL ANTIGEN RECEPTOR, IN HUMAN T-LYMPHOCYTES [J].
BEADLING, C ;
GUSCHIN, D ;
WITTHUHN, BA ;
ZIEMIECKI, A ;
IHLE, JN ;
KERR, IM ;
CANTRELL, DA .
EMBO JOURNAL, 1994, 13 (23) :5605-5615
[4]   Stat5a serine phosphorylation -: Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity [J].
Beuvink, I ;
Hess, D ;
Flotow, H ;
Hofsteenge, J ;
Groner, B ;
Hynes, NE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10247-10255
[5]   Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F [J].
Brennan, P ;
Babbage, JW ;
Burgering, BMT ;
Groner, B ;
Reif, K ;
Cantrell, DA .
IMMUNITY, 1997, 7 (05) :679-689
[6]  
Demoulin JB, 1996, MOL CELL BIOL, V16, P4710
[7]   DNA binding specificity of different STAT proteins -: Comparison of in vitro specificity with natural target sites [J].
Ehret, GB ;
Reichenbach, P ;
Schindler, U ;
Horvath, CM ;
Fritz, S ;
Nabholz, M ;
Bucher, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) :6675-6688
[8]   ANALYSIS OF INTERLEUKIN-2 DEPENDENT SIGNAL-TRANSDUCTION THROUGH THE SHC/GRB2 ADAPTER PATHWAY - INTERLEUKIN-2-DEPENDENT MITOGENESIS DOES NOT REQUIRE SHC PHOSPHORYLATION OR RECEPTOR ASSOCIATION [J].
EVANS, GA ;
GOLDSMITH, MA ;
JOHNSTON, JA ;
XU, WD ;
WEILER, SR ;
ERWIN, R ;
HOWARD, OMZ ;
ABRAHAM, RT ;
OSHEA, JJ ;
GREENE, WC ;
FARRAR, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) :28858-28863
[9]  
Gaffen Sarah L., 1998, P73
[10]   Recent advances in the understanding of interleukin-2 signal transduction [J].
Gesbert, F ;
Delespine-Carmagnat, M ;
Bertoglio, J .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (05) :307-320